CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.34B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.79: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
3.34%Below 5Y avg (3.78%)
Annual Rate
CNY 0.52Paid semi-annual
Payout Ratio
206.5%High
Payback Period
30.2 yr
Last Ex-Dividend
Jun 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.07BCNY1.34B · vs all stocks (USD)
Trailing P/E
61.23xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.60BCNY237.78M · vs all stocks (USD)
Profit Margin
9.79%vs Medical Instruments & Supplies peers
Beta
0.4900xvs all stocks
52-Week Change
-29.15%vs all stocks
Forward Annual Dividend Yield
3.34%vs all stocks
Market Capitalization
9.07BCNY1.34B · vs all stocks (USD)
Enterprise Value
6.63BCNY983.27M · vs all stocks (USD)
Trailing P/E
61.23xvs Medical Instruments & Supplies peers
Forward P/E
20.15xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
5.75xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.28xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.13xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
21.34xvs Medical Instruments & Supplies peers
Gross Margin
73.31%vs Medical Instruments & Supplies peers
Profit Margin
9.79%vs Medical Instruments & Supplies peers
Operating Margin
12.09%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.61%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.57%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.60BCNY237.78M · vs all stocks (USD)
Revenue per Share (TTM)
2.69CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-8.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.18BCNY174.58M · vs all stocks (USD)
EBITDA (TTM)
267.28MCNY39.64M · vs all stocks (USD)
Net Income (TTM)
156.94MCNY23.27M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-45.80%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
216.81MCNY32.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-321.34MCNY-47.65M · vs all stocks (USD)
Forward Annual Dividend Rate
0.5220CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
3.34%vs all stocks
Trailing Annual Dividend Rate
0.5230CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.35%vs all stocks
5-Year Average Dividend Yield
3.78%vs all stocks
Payout Ratio
206.54%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
73.98MCNYFY2025 · Dec 31, 2025Revenue
1.64BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
397.48MCNYFY2025 · Dec 31, 2025Gross Profit
1.24BCNYFY2025 · Dec 31, 2025Operating Income
210.49MCNY31.22M · vs all stocks (USD)
Pre-tax Income
175.08MCNYFY2025 · Dec 31, 2025Income Tax Expense
21.16MCNYFY2025 · Dec 31, 2025Net Income
153.92MCNYFY2025 · Dec 31, 2025EBIT
199.21MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
426.81MCNYFY2025 · Dec 31, 2025Research & Development
229.11MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
377.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.70MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
86.82MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
24.13MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
585.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
585.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
153.92MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
45.01MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
137.88MCNYFY2025 · Dec 31, 2025Free Cash Flow
-229.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.75BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
153.92MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.56MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-39.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.64MCNYFY2025 · Dec 31, 2025Capital Expenditures
-367.32MCNYFY2025 · Dec 31, 2025Net Acquisitions
-715.47MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.05BCNYFY2025 · Dec 31, 2025Sale of Investments
847.50MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.29BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.11BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-403.13MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-333.68MCNYFY2025 · Dec 31, 2025Other Financing Charges
4.58MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
374.38MCNYFY2025 · Dec 31, 2025Shares Outstanding
579.39MSharesUpdated Aug 19, 2026Float Shares
298.90MSharesUpdated Aug 19, 2026% Held by Insiders
47.67%vs all stocks
% Held by Institutions
7.94%vs all stocks
Total Cash (MRQ)
3.92BCNY581.78M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.82CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.18BCNY175.10M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1633xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.26xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.46CNYUpdated Aug 19, 2026Total Assets
9.53BCNY1.41B · vs all stocks (USD)
Total Current Assets
5.27BCNYFY2025 · Dec 31, 2025Total Liabilities
2.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.13BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.21BCNYFY2025 · Dec 31, 2025Cash
3.84BCNYFY2025 · Dec 31, 2025Cash Equivalents
125.17MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.97BCNYFY2025 · Dec 31, 2025Other Short-term Investments
157.10MCNYFY2025 · Dec 31, 2025Accounts Receivable
621.44MCNYFY2025 · Dec 31, 2025Inventory
413.69MCNYFY2025 · Dec 31, 2025Accounts Payable
364.79MCNYFY2025 · Dec 31, 2025Short-term Debt
148.85MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.31MCNYFY2025 · Dec 31, 2025Long-term Debt
978.47MCNYFY2025 · Dec 31, 2025Common Stock (Book)
579.39MCNYFY2025 · Dec 31, 2025Retained Earnings
4.79BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.19BCNY1.07B · vs all stocks (USD)
Treasury Stock
143.23MCNYFY2025 · Dec 31, 202552-Week Low
13.40CNYUpdated Aug 19, 202652-Week High
22.94CNYUpdated Aug 19, 202652-Week Change
-29.15%vs all stocks
Beta
0.4900xvs all stocks
50-Day MA
15.04CNYUpdated Aug 19, 2026200-Day MA
17.95CNYUpdated Aug 19, 2026Avg 10-Day Volume
7.71MSharesUpdated Aug 19, 2026Avg 30-Day Volume
6.30MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2600CNYUpdated Aug 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.07Dividend per Share: 0.52Earnings per Share: 0.26
Financial Health
Altman Z-Score 3.79: safe zoneNotable
Altman Z-Score: 3.79
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.34B, above the global median of $1.15BNotable
Market cap (USD): 1,344,698,726.052Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen Desay Battery Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chongqing Chuanyi Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Sacred Sun Power Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shikun & Binui Soltec Renewable Energy Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Corbion N.V.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Shunho New Material Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
C*Core Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Trident Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Windey Energy Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xingye Leather Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
China Tourism Group Duty Free Corporation Limited
3 interpretationsHigh Retained Earnings With Profitability And EquityCash Elevated Relative to Current Liabilities and Total AssetsRetained Earnings Heavy With Elevated Payout
Zhejiang Jianye Chemical Co., Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityCash Elevated Relative to Current Liabilities and Total AssetsRetained Earnings Heavy With Elevated Payout
Zhenhai Petrochemical Engineering Co., Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityCash Elevated Relative to Current Liabilities and Total AssetsRetained Earnings Heavy With Elevated Payout